Multifaceted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: A randomized controlled trial

Arthritis Care and Research

Volumn 51, Issue 3, 2004, Pages 383-387

  Solomon, Daniel H ^a,b   Katz, Jeffrey N ^a   La Tourette, Alison M ^a   Coblyn, Jonathan S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bone densitometry; Education; Glucocorticoids; Guidelines; Osteoporosis; Randomized controlled trial

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CORTICOSTEROID; ETIDRONIC ACID; GLUCOCORTICOID; PAMIDRONIC ACID; RALOXIFENE; RISEDRONIC ACID; VITAMIN D;

ADULT; AGED; ARTHRITIS; ARTICLE; BONE DENSITY; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; DRUG INDUCED DISEASE; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; OSTEOPOROSIS; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS;

EID: 2642571903     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20403     Document Type: Article

References (19)

1. Michel BA, Bloch DA, Wolfe F, Fries JF. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol 1993;20:1666-9.
2. Hooyman JR, Melton III LJ, Nelson AM, O'Fallon WM, Riggs BL. Fractures after rheumatoid arthritis: a population based study. Arthritis Rheum 1984;27:1353-61.
3. Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TE. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis. Arthritis Rheum 2000;43: 522-30.
4. Laan RFJ, van Riel PLCM, van de Putte LBA, van Erning LJ, van't Hof MA, Lemmens JA. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis: a randomized controlled trial. Ann Intern Med 1993; 119:963-8.
5. Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000;15:993-1000.
6. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, et al, Glucocorticoid-Induced Osteoporosis Intervention Study Group. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 1998;339:292-9.
7. Adachi J, Cranney A, Goldsmith CH, Bensen WG, Bianchi F, Cividino A, et al. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss. J Rheumatol 1994;21:1922-6.
8. Cohen S, Levy RM, Keller M, Boling E, Emkey RD, Greenwald M, et al. Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum 1999;42:2309-18.
9. American College of Rheumatology Task Force on Oteoporosis Guidelines. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arhritis Rheum 1996;39:1791-1801.
10. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 2001;44:1496-503.
11. Eastell R, Reid DM, Compston J, Cooper C, Fogelman I, Francis RM, et al. A UK consensus group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 1998;244:271-92.
12. Aagaard EM, Lin P, Modin GW, Lane NE. Prevention of glucocorticoid-induced osteoporosis: provider practice at an urban hospital. Am J Med 1999;107:456-60.
13. Yood RA, Harrold LR, Fish L. Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting. Arch Intern Med 2001;161:1322-7.
14. Mudano A, Allison J, Hill J, Rothermel T, Saag K. Variations in glucocorticoid-induced osteoporosis prevention in a managed care cohort. J Rheumatol 2001;28:1298-1305.
15. Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheum 2002; 46:3136-42.
16. Haugeberg G, Orstavik RE, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years. Arthritis Rheum 2002;46:1720-8.
17. Davis D, O'Brien MAT, Freemantle N, Wolf FM, Mamanian P, Taylor-Vaisey A. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health outcomes? JAMA 1999;282:867-74.
18. Oxman AD, Thomson MA, David DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J 1995;153: 1423-31.
19. Localio AR, Berlin JA, Ten Have TR, Kimmel SE. Adjustments for center in multicenter studies: an overview. Ann Intern Med 2001;135:112-23.